Wearable-supported exercise guidance may improve walking capacity in type 2 diabetes

Moderate confidence

Some Concerns bias

Última actualización 11 de junio de 2026

Conclusión Clave:

This study tested monthly physiotherapist-led exercise guidance supported by wearable device feedback in people with type 2 diabetes, including diabetic kidney disease. Over six months, the intervention group walked farther and had lower HbA1c than the standard care group, while kidney filtration did not clearly change.

Estudio de un Vistazo

Qué se estudió

Wearable-supported physiotherapist exercise guidance for outpatients with type 2 diabetes.

Participantes

Middle Aged (40-64), Older Adults (65+)

Male, Female

with Chronic Kidney Diseasewith T2 Diabetes

Intervención

Exercise therapy

Resultados

6-minute walk distance, HbA1c, Weight-bearing index, Phase angle, Estimated glomerular filtration rate, Adverse events incidence

Financiamiento

No Patrocinado por la Industria

Guarda este estudio y agrega notas a tu biblioteca de investigación.

Efectos Principales

↑ 6-minute walk distance: adjusted between-group change +42.4 m at six months

↓ HbA1c: greater reduction in the intervention group than standard care

↔ eGFR: no clear short-term kidney filtration effect

Resumen de Evidencia

Intervention	Outcome	Measured Change	Study Effect
Exercise therapy (Physical Activity)	6-minute walk distance (Clinical Outcomes)	Increase	Strong
Exercise therapy (Physical Activity)	Adverse events incidence (Safety)	No Change	Limited
Exercise therapy (Physical Activity)	Estimated glomerular filtration rate (Clinical Outcomes)	No Change	Limited
Exercise therapy (Physical Activity)	HbA1c (Glycemic Control)	Decrease	Mixed
Exercise therapy (Physical Activity)	Phase angle (Metabolic Health)	Increase	Mixed
Exercise therapy (Physical Activity)	Weight-bearing index (Metabolic Health)	Increase	Mixed

Unlock Full Evidence Analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

Tener en Cuenta

Small single-center study with 45 per-protocol completers. Allocation is described, but randomization is not clearly reported in the excerpts. Secondary outcomes were exploratory and not formally adjusted for multiple comparisons. Follow-up was limited to six months.

Entre Líneas

Small single-center study with 45 per-protocol completers. Allocation is described, but randomization is not clearly reported in the excerpts. Secondary outcomes were exploratory and not formally adjusted for multiple comparisons. Follow-up was limited to six months.